Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Chembiochem : a European Journal of Chemical Biology|May 7, 2024
Chemical Production of Cytotoxic Bispecific Antibodies Using the Ugi Multicomponent ReactionValentine Vaur, Ilias Koutsopetras, Stéphane Erb, et al.
Cell Reports|April 5, 2018
Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated CarcinomasKhyati Meghani, Walker Fuchs, Alexandre Detappe, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2020
Anti-MUC1-C Antibody-Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation TherapyAlexandre Detappe, Clélia Mathieu, Caining Jin, et al.
Nano Letters|September 30, 2015
Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation TherapySijumon Kunjachan, Alexandre Detappe, Rajiv Kumar, et al.
ACS Nano|November 19, 2025
A Modular Supramolecular Peptide Platform Reveals Atomic-Number-Dependent Mechanisms Driving RadioenhancementSebastian Jung, Pedro Lopez Navarro, Elsa Barbé, et al.
Nanoscale|September 2, 2017
NIR-emissive PEG-b-TCL micelles for breast tumor imaging and minimally invasive pharmacokinetic analysisChristina L Hofmann, Melanie C O'Sullivan, Alexandre Detappe, et al.
Research (Washington, D.C.)|May 15, 2026
Artificial Intelligence Decodes Brain Elemental Signatures to Stratify Aging and Neurological DiseasesAugustin Tillement, Eszter Nemeth, Laurent David, et al.
Theranostics|February 25, 2016
Gadolinium-Based Nanoparticles and Radiation Therapy for Multiple Brain Melanoma Metastases: Proof of Concept before Phase I TrialShady Kotb, Alexandre Detappe, François Lux, et al.
Pharmacology Research & Perspectives|July 26, 2021
TROIKA-1: A double-blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, versus EU-Herceptin® and US-Herceptin® in healthy male subjectsMartin Demarchi, Pierre Coliat, Kristi Mclendon, et al.
Drugs in R&D|April 2, 2025
Comparative Preclinical Evaluation of Tuznue Versus Referent Herceptin: A Registered Trastuzumab BiosimilarHerve Bischoff, Neil K O'Connor, Jamie Kim, et al.
Pageof 7